Cargando…

Real-Life Experience of mTOR Inhibitors in Liver Transplant Recipients in a Region Where Living Donation Is Predominant

Background: Mammalian target of rapamycin (mTOR) inhibitors, such as everolimus and sirolimus, may be efficacious in preserving renal function in liver transplantation (LT) recipients while preventing hepatocellular carcinoma (HCC) recurrence. Materials and Methods: In this study, we retrospectively...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sung, Pil Soo, Han, Ji Won, Seo, Changho, Ahn, Joseph, Lee, Soon Kyu, Nam, Hee Chul, Choi, Ho Joong, You, Young Kyoung, Jang, Jeong Won, Choi, Jong Young, Yoon, Seung Kew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8314303/ https://www.ncbi.nlm.nih.gov/pubmed/34326770 http://dx.doi.org/10.3389/fphar.2021.685176

Ejemplares similares

Where is mTOR and what is it doing there?
por: Betz, Charles, et al.
Publicado: (2013)

CXCR2 Inhibition in Human Pluripotent Stem Cells Induces Predominant Differentiation to Mesoderm and Endoderm Through Repression of mTOR, β-Catenin, and hTERT Activities
por: Jung, Ji-Hye, et al.
Publicado: (2016)

Predominant Role of mTOR Signaling in Skin Diseases with Therapeutic Potential
por: Karagianni, Fani, et al.
Publicado: (2022)

Cancer and mTOR inhibitors in kidney transplantation recipients
por: Kao, Chih-Chin, et al.
Publicado: (2018)

Successful Sequential Therapy Involving Regorafenib after Failure of Sorafenib in a Patient with Recurrent Hepatocellular Carcinoma after Liver Transplantation
por: Lee, Soon Kyu, et al.
Publicado: (2020)

Patient-Derived Avatar Mouse Model to Predict the Liver Immune Homeostasis of Long-Term Stable Liver Transplant Patients
por: Lee, Soon Kyu, et al.
Publicado: (2022)

Mesoglycan attenuates VSMC proliferation through activation of AMP-activated protein kinase and mTOR
por: Lee, Kyung Young, et al.
Publicado: (2016)

Involvement of mTOR signaling in sphingosylphosphorylcholine-induced hypopigmentation effects
por: Jeong, Hyo-Soon, et al.
Publicado: (2011)

Silibinin Downregulates Types I and III Collagen Expression via Suppression of the mTOR Signaling Pathway
por: Choi, Sooyeon, et al.
Publicado: (2023)

mTOR Inhibitor Therapy and Metabolic Consequences: Where Do We Stand?
por: Kezic, Aleksandra, et al.
Publicado: (2018)

mTOR Inhibitors Induce Erythropoietin Resistance in Renal Transplant Recipients
por: Jefferies, Reece, et al.
Publicado: (2022)

Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients
por: Wehming, Mathis, et al.
Publicado: (2023)

Unexpected Improvement of Liver Function by Intravenous Immunoglobulin in a Steroid-Experienced Severe Alcoholic Hepatitis
por: Tak, Kwon Yong, et al.
Publicado: (2020)

Tenofovir disoproxil fumarate directly ameliorates liver fibrosis by inducing hepatic stellate cell apoptosis via downregulation of PI3K/Akt/mTOR signaling pathway
por: Lee, Sung Won, et al.
Publicado: (2021)

Tunable Synthesis of Predominant Semi-Ionic and Covalent Fluorine Bonding States on a Graphene Surface
por: Lee, Jae-Won, et al.
Publicado: (2021)

Overcoming mTOR Resistance Mutations with a New Generation mTOR Inhibitor
por: Rodrik-Outmezguine, Vanessa S., et al.
Publicado: (2016)

Real-World Outcomes of Nivolumab in Patients With Unresectable Hepatocellular Carcinoma in an Endemic Area of Hepatitis B Virus Infection
por: Sung, Pil Soo, et al.
Publicado: (2020)

microRNA-99a Restricts Replication of Hepatitis C Virus by Targeting mTOR and De Novo Lipogenesis
por: Lee, Eun Byul, et al.
Publicado: (2020)

Age-dependent changes in the protein expression levels of Redd1 and mTOR in the gerbil hippocampus during normal aging
por: CHOI, HEE-SOO, et al.
Publicado: (2016)

Apoptotic Effects of Xanthium strumarium via PI3K/AKT/mTOR Pathway in Hepatocellular Carcinoma
por: Kim, Juyoung, et al.
Publicado: (2019)

C-C motif chemokine receptor 1 (CCR1) is a target of the EGF-AKT-mTOR-STAT3 signaling axis in breast cancer cells
por: Shin, Soon Young, et al.
Publicado: (2017)

Loss of pex5 sensitizes zebrafish to fasting due to deregulated mitochondria, mTOR, and autophagy
por: Bhandari, Sushil, et al.
Publicado: (2023)

mTOR-Inhibition and COVID-19 in Kidney Transplant Recipients: Focus on Pulmonary Fibrosis
por: Granata, Simona, et al.
Publicado: (2021)

mTOR Pathway and mTOR Inhibitors in Head and Neck Cancer
por: Gao, Wei, et al.
Publicado: (2012)

The isothiocyanate sulforaphane inhibits mTOR in an NRF2-independent manner
por: Zhang, Ying, et al.
Publicado: (2021)

A decrease in functional microbiomes represented as Faecalibacterium affects immune homeostasis in long-term stable liver transplant patients
por: Lee, Soon Kyu, et al.
Publicado: (2022)

Reactivation of Hepatitis B Virus in HBsAg-Negative Patients with Hepatocellular Carcinoma
por: Jang, Jeong Won, et al.
Publicado: (2015)

Combination Treatment With Metformin and Tacrolimus Improves Systemic Immune Cellular Homeostasis by Modulating Treg and Th17 Imbalance
por: Lee, Soon Kyu, et al.
Publicado: (2021)

Whole blood viscosity is associated with extrahepatic metastases and survival in patients with hepatocellular carcinoma
por: Han, Ji Won, et al.
Publicado: (2021)

Preferential Expression of Programmed Death Ligand 1 Protein in Tumor-Associated Macrophages and Its Potential Role in Immunotherapy for Hepatocellular Carcinoma
por: Park, Dong-Jun, et al.
Publicado: (2021)

Immunological Markers, Prognostic Factors and Challenges Following Curative Treatments for Hepatocellular Carcinoma
por: Lee, Soon Kyu, et al.
Publicado: (2021)

Skin cancer in solid organ transplant recipients: are mTOR inhibitors a game changer?
por: Geissler, Edward K
Publicado: (2015)

Myelination and mTOR
por: Figlia, Gianluca, et al.
Publicado: (2017)

Body fatness and breast cancer risk in relation to phosphorylated mTOR expression in a sample of predominately Black women
por: Cheng, Ting-Yuan David, et al.
Publicado: (2021)

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
por: Zou, Zhilin, et al.
Publicado: (2020)

Diagnostic performance of serum exosomal miRNA-720 in hepatocellular carcinoma
por: Jang, Jeong Won, et al.
Publicado: (2022)

Comparison of tenofovir and entecavir on the risk of hepatocellular carcinoma and mortality in treatment-naïve patients with chronic hepatitis B in Korea: a large-scale, propensity score analysis
por: Lee, Sung Won, et al.
Publicado: (2020)

Significance of TERT Genetic Alterations and Telomere Length in Hepatocellular Carcinoma
por: Jang, Jeong-Won, et al.
Publicado: (2021)

Identification of mTOR inhibitor-resistant genes in cutaneous squamous cell carcinoma
por: Yu, Seong-Lan, et al.
Publicado: (2018)

Regulation of c-SMAC formation and AKT-mTOR signaling by the TSG101-IFT20 axis in CD4(+) T cells
por: Jeong, Jiung, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_k5suoj05hkajmo31kntrvhh8uq